Response to consultation on draft Guidelines for cross-selling practices

Go back

Question 2: Do you agree with the identified potential benefits of cross-selling practices?

Yes, we agree with the identified potential benefits of cross-selling practices.

Question 3: Do you agree with the identified potential detriment associated with cross-selling practices?

While we generally appreciate the outlined detriments, we think that the disclosure requirements as well as the provisions regarding organisation and conduct should remain appropriate and practicable. EU regulation such as the UCITS AIFMD and MiFID II framework and in future PRIIPs-Regulation set high standards regarding cost disclosure. The ESAs should make it clear that complying with these requirements should be regarded as sufficient cost disclosure unless the price for the bundle is higher than the price for each component.

Question 4: Please comment on each of the five examples in paragraph 13, clearly indicating the number of the example to which your comment(s) relate.

• Example 2: We do not agree with this example as being detrimental cross-selling practices. It rather seems a common business decision. Cross-selling practices should not be measured against business decisions to become valid in future.
• Example 5: A firm might not have a complete picture on what product the client already has and which a customer cannot benefit from. This is in particular the case for online sales where there is no advice given. Further, clients might not be aware that there is a specific advantage for the second product and it is hence appropriate for the firm to offer such product. The example should therefore be revised in a way that a firm should not offer products of which it explicitly knows that the customer cannot benefit from them.
• Example 1, 3, 4: We have no specific comment regarding these examples.

Question 5: Please comment on the proposed guidelines 1 and 5 as well as the corresponding examples, stating clearly in your response the guideline paragraph number to which your comment relates.

We do not agree with the obligation in Guideline 1, number 14. MiFID II requires a clear breakdown and aggregation of relevant costs. In addition, there are rules regarding cost disclosure for products such as UCITS. Cross-selling should not require additional cost disclosure except for cases in which there are differences between the cost of the package and the sum of the costs for parts of the package. In addition, the obligation to display prominently and communicate timely the key price and cost information should not be different from the MiFID II rules. It should be clarified that compliance with MiFID II rules regarding timing of disclosure and methodology meets the requirement of prominent display and timely communication of key price and cost information according to the guidelines.

Regarding the relevant non-price features and risks as addressed in Guideline 5, number 19 and the related illustrative example, it should be clarified that the requirements only apply if indeed features or risks change. This would also be in line with the mandate according to MiFID II which clearly states that the description will only be required where “the risks resulting from such an agreement or package offered to a retail client are likely to be different from the risks associated with the components taken separately” (Art. 24 para. 11 subpara. 2 MiFID II). If savings accounts are combined with e.g. investment products, in practice, there is often no change to the risk of the saving account, because the capital invested in the saving account is guaranteed. In such case, the other product does not influence the risk profile of the savings account and hence no communication regarding a different overall risk profile is required. We would appreciate a clarification in this regard.

Question 6: Please comment on the proposed guidelines 2, 3, 4 and 6 as well as the corresponding examples, stating clearly in your response the guideline paragraph number to which your comment relates.

Guideline 3 requires that equal prominence is assigned to the price and cost information on the component products. This bears a huge burden to firms. The services and products sold in a bundle might come from different sectors and hence have to comply with different disclosure obligations. The point of sale will only have available the disclosure according to the different sectorial legislation. These disclosure obligations which are sufficient according to the sectorial legislation may no longer be sufficient according to the proposed guidelines. The guidelines in particular propose that equal prominence is given to the price and cost information of the component products (see Guideline 3, number 17). As long as the disclosure obligations under each sectorial legislation are not identical, this rule is neither feasible nor in line with the legislation. None of the cross-selling rules within MiFID II, MCD, PAD and draft IMD II allow different disclosure requirements to those provided for in the respective directives and implementing acts. The rules only allow and require that the costs of each component shall be disclosed. Therefore, the information cannot be presented together but only subsequently for each product and / or service. In addition, the investor can only take into account one information at a time. It is neither practicable nor in line with the ESA’s mandate and the respective disclosure requirements to request an additional or different type of disclosure in the case of cross-selling. In this regard, the guidelines should clarify the meaning of “equal” by clarifying that disclosure of each component according to the respective rules as well as disclosure of the package costs should be sufficient.

Further, we see potential conflicts between on the one hand the requirements of cost transparency as proposed by ESMA under MiFID II, the requirement for cost disclosure within PRIIPs Regulation and on the other hand the requirements of cost disclosure in other EU regulations. For instance, MiFID II Level 2 and PRIIPs Regulation will require disclosure of costs not only in percentage but also in monetary terms. If a MiFID service, however, is offered together with a product neither falling under MiFID II nor under PRIIPs Regulation, monetary terms might not be available. It should therefore be clear that no additional disclosure of price and cost information will be imposed (see Guideline 4 and related illustrative example). Otherwise, the highest cost disclosure standard will proliferate to all other products and services although the rules applicable to such product and service do not require such disclosure. Such understanding would contradict the rules for such products and services and might even hinder the cross-selling which – as the ESAs pointed out – can have advantages for the customer.

Question 7: Please comment on the proposed guideline 7 as well as the corresponding examples, stating clearly in your response the guideline paragraph number to which your comment relates.

Guideline 7, Number 23 indicates that firms are required to sell the components separately. This is not the case. MiFID II for example states the requirement to disclose whether the components may be purchased separately. The guideline should be clarified in this respect.

Question 8: Please comment on the proposed guideline 8 as well as the corresponding examples, stating clearly in your response the guideline paragraph number to which your comment relates.

We disagree with the example 1) described in Guideline 8 since it does not differentiate clearly between the appropriateness and suitability test. It is correct that in case of MiFID services other than advice and portfolio management, the appropriateness of a bundled package has to be assessed. Unlike the suitability test, the appropriateness does not include an assessment of the customers’ financial situation and investment objectives. This should not be changed for cross-sold components. It has to be clear that in case the firm is obliged to assess the appropriateness, the assessment relates to the customers experience and knowledge. The requirement to assess or evaluate a potential benefit of the cross-sold components for the client would in fact trigger a suitability test in case a non-advised cross-selling takes place. This is not in line with the understanding of MiFID II regarding suitability and appropriateness and should therefore be revised.

The same applies to example 4 which includes the reference to the example in Guideline 5. Example 4 discusses that the package should be deemed suitable without any reference to the service provided. Suitability, however, is under MiFID II only required in case of investment advice or portfolio management. There is no reference to these services in the examples. This should be reviewed accordingly.

Question 9: Please comment on the proposed guidelines 9 and 10 as well as the corresponding examples, stating clearly in your response the guideline paragraph number to which your comment relates.

Although we appreciate that the obligations in guidelines 9 and 10 follow obligations for firms which fall under MiFID II, we fear that the wording different from MiFID II may lead to other interpretations and potentially new obligations. Generally, the organisational rules regarding training of staff and remuneration would also apply to bundled packages without any inclusion in the guidelines. MiFID II provides for high standards also for staff remuneration and staff training. Hence, it should be made clear that complying with MiFID II requirements suffices also with respect to bundled package.

Question 10: Please comment on the proposed guideline 11 as well as the corresponding examples, stating clearly in your response the guideline paragraph number to which your comment relates.

We strongly object against the rule in guideline 11, number 29, to allow the customer to split the products grouped in a cross-selling offer. This goes far beyond the mandate for the cross-selling guidelines and the rules on cross-selling. These clearly indicate that the firm is allowed to offer the products only in bundled form. Hence, an obligation to subsequently split grouped products is not in line with the ESAs’ mandate. In addition, the customer has to be informed in advance whether or not the components may be purchased separately. The customer therefore knows the circumstances when buying the package. A requirement to disclose whether or not the components may be split subsequently and at what price should be sufficient.

Question 11: Please provide any specific evidence or data that would further inform the analysis of the likely cost and benefit impacts of the guidelines.

The cross-selling Guidelines should not create additional disclosure requirements which contradict or go beyond the existing sectorial legislations. For MiFID firms compliance with the MiFID II standards for bundled products should suffice.

Upload files

Name of organisation

BVI